Globe Newswire02.09.22
Silver Bullet Therapeutics Inc. has officially unveiled its antimicrobial OrthoFuzIon Bone Screw System in Europe.
“Silver Bullet is very excited to be launching our product line with Argomedical, our respected distribution partner. Patients who receive revision surgery due to an implant related infection or those that are at risk of implant infections from a primary surgery will benefit from the technology and significantly broad product offering,” stated Silver Bullet President/CEO Paul Chirico.
The OrthoFuzIon Orthopedic Bone Screw System is a comprehensive antimicrobial bone screw product line for orthopedic procedures. The OrthoFuzIon Bone Screws are indicated for open reduction and internal fixation (ORIF) fracture surgeries and are plated to inhibit microbial colonization and reduce implant related infection in revision surgery due to implant infection or primary surgery in patients who are at-risk of implant infections. The OrthoFuzIon Bone Screw System uses Silver Bullet Therapeutics proprietary blend of platinum and silver technology, called AntiBacterIon, that allows for rapid ionization of silver and creation of an antimicrobial zone around a bone screw anywhere in the body.
A 2015 article in the Journal of the American Academy of Orthopedic Surgery stated: “Musculoskeletal infections are a leading cause of patient morbidity and rising healthcare expenditures. The incidence of musculoskeletal infections, including soft-tissue infections, periprosthetic joint infection, and osteomyelitis, is increasing. Cases involving both drug-resistant bacterial strains and periprosthetic joint infection in total hip and total knee arthroplasty are particularly costly and represent a growing economic burden for the American healthcare system.” Silver Bullet Therapeutics has developed a coating for bone screws since they penetrate the cortical shell of a bone into the intramedullary space to not only alleviate the morbidity and the costs associated orthopedic infection complications, but minimize the disincentive on caring for high-risk patients."
The OrthoFuzIon coating is a combination of platinum and silver which, when the coating interacts with the body, causes a “galvanic” reaction wherein silver wears away gradually, creating a localized “cloud” of silver ions that surrounds the implanted device and is designed to be a deterrent to bacterial colonization.
“Orthopedic trauma surgeons treat challenging injuries in patients that may have complex medical comorbidities. I believe that The Silver Bullet Therapeutics antimicrobial OrthoFuzIon Bone Screw line, which delivers local peri-implant antimicrobial silver ions, will help us decrease surgical infection complications after surgical fixation,” noted Amir Matityahu, M.D., an internationally renowned orthopedic trauma surgeon, professor of Orthopaedic Surgery at the University of California, San Francisco, and chairman of Surgery, chief of Orthopaedics, and director of Orthopedic Trauma at Regional Medical Center of San Jose. He is also a Fellow of the American Academy of Orthopedic Surgery and International Corresponding Member of the German Society for Orthopaedics and Trauma (Deutsche Gesellschaft für Orthopädie und Unfallchirurgie e V.).
Silver Bullet Therapeutics has built an intellectual property portfolio that has allowed the company to develop and validate coating processes for various of metallic, polymer, and electronic medical devices.
“Argomedical has a history of representing products that directly benefit patients and surgeons”, said Phil Kropf, CEO of Argomedical. “The Silver Bullet Therapeutics’ antimicrobial OrthoFuzIon Bone Screw System is not only simple but a disruptive medical device that may change the practice of trauma orthopedics almost immediately.”
Silver Bullet Therapeutics Inc., located in San Jose, Calif., has developed and patented antimicrobial coatings to address surgical-site and hospital-acquired infections by preventing microbial colonization of implanted medical devices. Silver Bullet Therapeutics has already developed and validated processes to allow coating of a wide range of devices including both metallic and polymer devices. OrthoFuzIon and AntiBacterIon are trademarks of Silver Bullet Therapeutics, and is pending U.S. Food and Drug Administration clearance. It is not yet approved for sale in the United States.
Since 1989 Argomedical has developed, produced, and marketed products for orthopedics and traumatology.
“Silver Bullet is very excited to be launching our product line with Argomedical, our respected distribution partner. Patients who receive revision surgery due to an implant related infection or those that are at risk of implant infections from a primary surgery will benefit from the technology and significantly broad product offering,” stated Silver Bullet President/CEO Paul Chirico.
The OrthoFuzIon Orthopedic Bone Screw System is a comprehensive antimicrobial bone screw product line for orthopedic procedures. The OrthoFuzIon Bone Screws are indicated for open reduction and internal fixation (ORIF) fracture surgeries and are plated to inhibit microbial colonization and reduce implant related infection in revision surgery due to implant infection or primary surgery in patients who are at-risk of implant infections. The OrthoFuzIon Bone Screw System uses Silver Bullet Therapeutics proprietary blend of platinum and silver technology, called AntiBacterIon, that allows for rapid ionization of silver and creation of an antimicrobial zone around a bone screw anywhere in the body.
A 2015 article in the Journal of the American Academy of Orthopedic Surgery stated: “Musculoskeletal infections are a leading cause of patient morbidity and rising healthcare expenditures. The incidence of musculoskeletal infections, including soft-tissue infections, periprosthetic joint infection, and osteomyelitis, is increasing. Cases involving both drug-resistant bacterial strains and periprosthetic joint infection in total hip and total knee arthroplasty are particularly costly and represent a growing economic burden for the American healthcare system.” Silver Bullet Therapeutics has developed a coating for bone screws since they penetrate the cortical shell of a bone into the intramedullary space to not only alleviate the morbidity and the costs associated orthopedic infection complications, but minimize the disincentive on caring for high-risk patients."
The OrthoFuzIon coating is a combination of platinum and silver which, when the coating interacts with the body, causes a “galvanic” reaction wherein silver wears away gradually, creating a localized “cloud” of silver ions that surrounds the implanted device and is designed to be a deterrent to bacterial colonization.
“Orthopedic trauma surgeons treat challenging injuries in patients that may have complex medical comorbidities. I believe that The Silver Bullet Therapeutics antimicrobial OrthoFuzIon Bone Screw line, which delivers local peri-implant antimicrobial silver ions, will help us decrease surgical infection complications after surgical fixation,” noted Amir Matityahu, M.D., an internationally renowned orthopedic trauma surgeon, professor of Orthopaedic Surgery at the University of California, San Francisco, and chairman of Surgery, chief of Orthopaedics, and director of Orthopedic Trauma at Regional Medical Center of San Jose. He is also a Fellow of the American Academy of Orthopedic Surgery and International Corresponding Member of the German Society for Orthopaedics and Trauma (Deutsche Gesellschaft für Orthopädie und Unfallchirurgie e V.).
Silver Bullet Therapeutics has built an intellectual property portfolio that has allowed the company to develop and validate coating processes for various of metallic, polymer, and electronic medical devices.
“Argomedical has a history of representing products that directly benefit patients and surgeons”, said Phil Kropf, CEO of Argomedical. “The Silver Bullet Therapeutics’ antimicrobial OrthoFuzIon Bone Screw System is not only simple but a disruptive medical device that may change the practice of trauma orthopedics almost immediately.”
Silver Bullet Therapeutics Inc., located in San Jose, Calif., has developed and patented antimicrobial coatings to address surgical-site and hospital-acquired infections by preventing microbial colonization of implanted medical devices. Silver Bullet Therapeutics has already developed and validated processes to allow coating of a wide range of devices including both metallic and polymer devices. OrthoFuzIon and AntiBacterIon are trademarks of Silver Bullet Therapeutics, and is pending U.S. Food and Drug Administration clearance. It is not yet approved for sale in the United States.
Since 1989 Argomedical has developed, produced, and marketed products for orthopedics and traumatology.